Latest News Releases
-
27.11.2009Major European regulatory milestone in cardiovascular protection for Micardis® (telmisartan): Now approved by the European Commission to reduce the risk of cardiovascular (CV) morbidity in high CV risk patients
For medical media, outside the US only -
16.11.2009Flibanserin demonstrates efficacy and tolerability in pivotal Phase III Trials in pre-menopausal women with Hypoactive Sexual Desire Disorder (HSDD)
For medical media, outside the US only
Upcoming Event
|
06 December 2009
|
|
 |
The results of the landmark RE-COVER™ studyThe RE-COVER™ trial results shed light on an important indication for anticoagulation: Acute Venous Thromboembolism. |
Latest event
|
17 November 2009
|
|
 |
The Science of Desire: New Discoveries in HSDDHypoactive Sexual Desire Disorder (HSDD) and its impact on women's life. |
Information Packs
 |
Download current information material, sorted by indication areas and clinical trials:Compilations of the most relevant documents, images, videos and interesting links. Information packs |
